R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL

NCT01148446 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

226

Enrollment

OTHER

Sponsor class

Conditions

Elderly Patients (>65 Years)
Diffuse Large B Cell Lymphoma (DLBCL)

Interventions

DRUG: Cyclophosphamide
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Prednisone
DRUG: Epirubicin
DRUG: Vinblastine
DRUG: Rituximab
DRUG: G-CSF

Sponsor

Fondazione Italiana Linfomi - ETS